Historial del iniciado
OtroTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the full record of transactions filed by Lee Jennifer Kayden. Insider active across 1 company, notably Rhythm Pharmaceuticals, INC.. In total, 20 disclosures have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €8.7m. Activity tracked since 7 August 2023. The latest transaction was disclosed on 13 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lee Jennifer Kayden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones20 en total
35.000 títulos@ 24,29 US$0.011% mcap7.4% de su flujoCommon StockSEC:0001649904-26-000009:0
21.601 títulos@ 6,80 US$0.0018% mcap1.3% de su flujoCommon StockSEC:0001649904-26-000009:1
75.834 títulos@ 117,3818 US$0.11% mcap77.8% de su flujoCommon StockSEC:0001649904-26-000009:2
22.612 títulosCommon StockSEC:0001104659-26-009767:0
5500 títulosCommon StockSEC:0001104659-25-015320:0
600 títulos@ 56,39 US$2.4% de su flujoCommon StockSEC:0001104659-25-014257:0
3437 títulosCommon StockSEC:0001104659-25-011677:0
1733 títulos@ 60,0811 US$7.5% de su flujoCommon StockSEC:0001104659-25-010610:0
4513 títulosCommon StockSEC:0001104659-25-009284:0
20.622 títulos@ 6,80 US$9.8% de su flujoCommon StockSEC:0001104659-24-117942:0
9169 títulos@ 38,22 US$24.1% de su flujoCommon StockSEC:0001104659-24-037880:0
15.515 títulos@ 39,22 US$41.7% de su flujoCommon StockSEC:0001104659-24-036312:0
33.750 títulos0Common StockSEC:0001104659-24-026154:0
3438 títulosCommon StockSEC:0001104659-24-022538:0
4513 títulosCommon StockSEC:0001104659-24-010800:0
12.030 títulos@ 6,80 US$5.7% de su flujoCommon StockSEC:0001104659-23-119095:0
5712 títulos@ 6,80 US$2.7% de su flujoCommon StockSEC:0001104659-23-117365:0
80 títulos@ 6,80 US$0.0% de su flujoCommon StockSEC:0001104659-23-115368:0
4519 títulos@ 6,80 US$2.1% de su flujoCommon StockSEC:0001104659-23-099017:0
8591 títulos@ 6,80 US$4.0% de su flujoCommon StockSEC:0001104659-23-089331:0
About Lee Jennifer Kayden
Lee Jennifer Kayden is a declarant linked to Rhythm Pharmaceuticals, INC., where she holds the role of EVP, Head of North America. The record shows 17 filings in total, and across the 17 sampled filings between 2023-08-09 and 2026-02-03, sales total 1015204 EUR, with Levée d'options as the most frequent transaction nature.